1.Experimental study on biodistribution and PET imaging of 3′-deoxy-3′-~(18)F-fluorothymidine in murine model of lung carcinoma
Xi LIU ; Naikang ZHOU ; Jinming ZHANG
Medical Journal of Chinese People's Liberation Army 2001;0(10):-
Objective To investigate the biodistribution and positron emission tomography (PET) imaging of 3′-deoxy-3′-~ 18 F-fluorothymidine (~ 18 F-FLT) in a murine model of pulmonary carcinoma, and to evaluate the use of ~ 18 F-FLT as a new PET tracer for diagnosis of pulmonary malignant tumor. Methods 40 T739 mice bearing the pulmonary adenocarcinoma were randomly divided into five groups according to different tracers and time after their injection (n=8/group). The biodistribution of mice for ~ 18 F-FLT was measured with well-gamma detector at 30min, 60min, 90min, 120min after injection via the tail veins. The biodistribution of mice for ~ 18 F-FDG was examined at 60min after injection as controls. In addition, the PET imaging of mice was performed using two tracers. Results In the biodistribution study of ~ 18 F-FLT, considerable radioactive uptake in tumor was observed, and high radioactivity was showed in the kidney and spleen. The T/NT ratios of tumor/blood, tumor/muscle and tumor/lung was all above 2.0. The tumor PET images with ~ 18 F-FLT were clear, as well. Conclusions The uptake of ~ 18 F-FLT in pulmonary adenocarcinoma is higher than that in normal tissues, thus the pulmonary neoplasm could be identified accurately with PET imaging. Our preliminary study of ~ 18 F-FLT in lung carcinoma xenografts is satisfactory, and it provides a basis for further clinical study.
2.Clinical analysis of pleuropneumonectomy for lung cancer with diffuse pleural metastasis accompanied by malignant pleural effusion
Jin ZHANG ; Naikang ZHOU ; Yang LIU
Medical Journal of Chinese People's Liberation Army 2001;0(07):-
Objective To investigate a novel therapeutic strategy in the treatment of lung cancer with diffuse pleural metastasis accompanied by malignant pleural effusion. Methods From December 1978 to February 2003, 55 patients of carcinoma of lung with pleural metastasis underwent the comprehensive therapy characterized by pleuropneumonectomy. A follow-up of all the patients after hospital discharge was conducted. Results Death due to complications was found in 2 out of the 55 patients, but remission and significant improvement of symptoms were found in the rest. A follow-up period ranging from 1 to 25 years revealed that 48 patients survived for 5-40 months (median survival time: 14 months), and 5 patients were still living and well. Conclusion Strict control of the surgical indications and radical removal of the malignant tumor can improve the quality of life and prolong the survival time of patients, even there is already metastasis to the pleura.
3.The value of intraoperative ultrasonography in judging the resectability of central bronchogenic carcinoma: a comparison with computed tomography
Naikang ZHOU ; Xiaodong TIAN ; Junlai LI
Medical Journal of Chinese People's Liberation Army 2001;0(11):-
Objective To evaluate the accuracy of intraoperative ultrasonography (IUS) in judging the relationship between central bronchogenic carcinoma and pulmonary vessels and in predicting the resectability of the tumor. Methods Intraoperative ultrasonograpy(IUS) and preoperative CT scanning were performed in 30 patients of central bronchogenic carcinoma. The relationship between vessel and tumor as assessed by IUS and preoperative CT were quantified and scored with a ranging from 0-4 respectively, and then the resectability of the tumor and optimal surgical method were predicted according to the scores. Results The accuracy of CT and IUS to determine tumor-vessel relationship was 72.3%(141/195) and 81.0%(171/211), respectively (P=0.037). The sensitivity of CT and IUS in predicting the resectability of tumor was 91.3%(21/23) and 95.6%(22/23), respectively, the specificity was 28.6%(2/7) and 57.1%(4/7), respectively, and the accuracy was 76.7%(23/30) and 86.7%(26/30), respectively. The accuracy of CT and IUS in predicting surgical strategy was 53.3%(16/30) and 63.3%(19/30), respectively(P=0.432). Conclusion IUS is a useful method in predicting the resectability of centrally located bronchogenic carcinoma.
4.Comparative study on the killing effect between hypocrellins B-photodynamic therapy and hematoporphyrin derivative-photodynamic therapy on human lung cancer cells
Naikang ZHOU ; Liqun SHANG ; Xi LIU
Medical Journal of Chinese People's Liberation Army 2001;0(12):-
Objective To study the killing effect of hypocrellins B-photodynamic therapy (HB-PDT) for lung cancer cell line A549, to compare with that of hematoporphyrin derivative-photodynamic therapy (HpD -PDT), in order to define the superiority of HB-PDT in the therapy of lung cancer. Methods Lung cancer cell line A549 was used in the study. The cells were incubated in vitro with HB or HpD dissolved in DMEM in different concentrations, and then irradiated by copper vapor laser with mixed wavelength light under saturated light dose. Cell survival rate was respectively measured by MTT assay after 24 hours' incubation. According to cell survival curves after being cultured with different photosensitizers in different concentrations, the equation of each cell survival curve was plotted. Finally IC 50 (50% inhibition concentration) of each photosensitizer was derived. Results The results showed that HB-PDT had a strong killing effect on lung cancer cell. The IC 50 of HB was 33.82ng/ml for lung cancer cell, while the IC 50 of HpD was 1 316.88ng/ml, which was 38.94 fold of that of HB. Conclusions HB was a more effective photosensitizer than the photosensitizer HpD. HB-PDT had strong photodynamic killing effect on lung cancer cell line.
5.Clinical significance and prognostic value of the expression of LRP16 gene in lung cancer
Chaoyang LIANG ; Huifeng LIU ; Naikang ZHOU
Medical Journal of Chinese People's Liberation Army 1983;0(05):-
Objective To investigate the expression of LRP16 gene in lung cancer, and explore its clinicopathological significance. Methods Fresh resected tissues from 54 patients with primary lung cancer were collected and the clinicopathological data were gathered. The expression of LRP16 protein in cancer tissues and the matched normal tissues were determined by Western blotting, and the relationship between LRP16 expression and clinicopathological data was analyzed. It was defined as overexpression when the LRP16 expression of cancer tissues was twice or more higher than that of matched normal tissues. Results The LRP16 was overexpressed in 15 out of 54 patients with lung cancer (27.8%). Among the 23 patients with adencarcinoma, the overexpression of LRP16 was found in 11 cases (47.8%), while in the patients with squamous carcinoma, the overexpression of LRP16 was only found in 4 out of 27 cases (14.8%), and there was a significant difference between the two groups (Pearson test, P=0.0258). Besides, very low expression or non-expression of LRP16 was found in 2 large cell lung cancer and 2 small cell lung cancer. The overexpression rate of LRP16 was 20.0% (2/10) in tumor with diameter less than 3cm and 29.5% (13/44) in tumor with diameter ≥3cm, and there was no significant difference between the two groups (Pearson test, P=0.7224). Conclusions There were significant differences of LRP16 overexpression in cases of adencarcinoma or squamous carcinoma with or without lymphatic metastasis. It is suggested that LRP16 is a tumor-related gene of lung cancer, and may play an important role in molecular staging of lung cancer.
6.Diagnosis and surgical treatment of thymoma: a report of 120 cases
Qing ZHANG ; Yang LIU ; Naikang ZHOU
Medical Journal of Chinese People's Liberation Army 1983;0(02):-
Objective To summarize the experiences in diagnosis and treatment of thymoma in 120 cases. Methods 120 patients with thymoma were operated on, and the diagnosis was confirmed pathologically, from January 1994 to December 2003 in our department. According to Masaoka clinical and pathological classification, 54 cases were stage Ⅰ, 32 were stage Ⅱ, 22 were stage Ⅲ, 12 were stage Ⅳ. In 42 cases there were symptoms of myasthenia gravis. Result Total excision was performed in 112 cases and partial excision in 8 cases. When the tumor was beyond stage Ⅱ, postoperative radiotherapy was given. Recurrence occurred in 5 patients 1-7 years after operation. Conclusions Surgical resection is currently the main therapeutic method for tumor of the thymus. The preferred surgical approach was excision of thymoma and removal of perithymic fat in the anterior mediastinum through a median sternotomy. Thymoma is a potentially malignant disease, and the patients with the tumor beyond stage Ⅰ must undergo postoperative radiotherapy. Local recurrence of the tumor should be surgically excised.
7.The clinical value of combined detection of CEA, NSE and CYFRA21-1 in differential diagnosis of lung cancer
Jianxin ZUO ; Yang LIU ; Naikang ZHOU
Medical Journal of Chinese People's Liberation Army 1982;0(01):-
Objective To compare the levels of serum CEA, NSE and CYFRA21-1 of patients with lung cancer and those with benign lung diseases, and to evaluate the clinical differential diagnostic value of combined detection of serum CEA, NSE and CYFRA21-1 in patients with lung cancer. Methods CEA, NSE and CYFRA21-1 were determined with enzyme-linked immunosorbent assay in 122 patients with lung cancer and 37 patients with benign lung diseases. The data was analyzed by t test. Results The serum levels of CEA(12.95?33.04ng/ml), CYFRA21-1(4.87?0.638ng/ml) in patients with lung cancer were significantly higher than that in those with benign lung diseases (1.92?0.84ng/ml and 4.87?0.638ng/ml, respectively)(P0.05). The levels of serum CEA, NSE and CYFRA21-1 were related to types of pathology. The highest levels of CEA, NSE and CYFRA21-1 appeared in adenocarcinoma, small cell carcinoma and squamous cell carcinoma, respectively. The level of serum of NSE (26.05?20.69ng/ml) in patients with small cell carcinoma was significantly higher than that of the patients with benign lung disease, adenocarcinoma (11.26?6.97ng/ml) and squamous cell carcinoma (12.71?7.64ng/ml), respectively (P0.05). Conclusion Combined determination of serum levels of CEA, NSE and CYFRA21-1 is helpful in differential diagnosis of lung cancers.
8.Surgical treatment of intrathoracic Castleman′s disease
Naikang ZHOU ; Bo WANG ; Chaoyang LIANG
Medical Journal of Chinese People's Liberation Army 1983;0(02):-
Objective To review and sum up the clinicopathologic features and surgical therapeutic efficacy of intrathoracic Castleman′s disease (CD). Methods 14 patients with intrathoracic Castleman′s disease, 7 in each sex, aged from 19 to 52, admitted during 1982 to 2005, all underwent surgical treatment, among which 11 with localized type and 3 with multicentric type, were retrospective analyzed on their clinicopathologic features, radiological signs, treatment and prognosis. Results Clinically, 3 patients of localized type were with systematic symptoms; all the patients of multicentric type were with various severity systematic symptoms. Pathological type: 9 cases with hyaline vascular type (HV), 2 cases with Plasma type (PC), and 3 cases with Mixed type (Mix). A different pattern of pathologic alterations existed between HV、PC and Mix types of CD. Radiological features: in localized type of CD, the lesion presented as a solitary soft-tissue mass with a mean diameter of 5.05cm, the mean CT value was 37.39HU. In 3 cases with multicentric type of CD, diffuse mediastinal lymphadenopathy and pleural effusion were observed. All patients survived after surgical resection, long-term survival was achieved in 11 cases with localized type and 2 cases with multicentric type, no recurrence occurred in the 13 patients. Recurrence occurred twice in a patient with multicentric Mix type in the fourth and the ninth year after surgery, respectively, thus the operative treatment followed. Conclusions The diagnosis of CD is based mainly on its histopathological features. The patients with intrathoracic localized type of CD and part of the patients with multicentric type CD could be cured, while part of the patients with multicentric type CD got a poor therapeutic efficacy and unfavorable prognosis even underwent with radiotherapy and integrated treatment.
9.Diagnosis and therapy of adult diaphragmatic eventration:a report of 26 cases
Huifeng LIU ; Naikang ZHOU ; Chaoyang LIANG
Medical Journal of Chinese People's Liberation Army 1982;0(03):-
Objective To summarize the characteristics on diagnosis and therapy of adult diaphragmatic eventration. Method The clinical data of 26 patients with adult diaphragmatic eventration, hospitalized in General Hospital of PLA from 1988 to 2009, were retrospectively analyzed. The 26 patients, 14 males and 12 females, were aged from 26 to 66 (mean 44.0?5.7), with disease course of 8 months to 17 years. Among them 25 suffered from left and 1 from right diaphragmatic eventration; 24 with total and 2 with localized diaphragmatic eventration; of them 2 without symptoms were detected in physical examination, and among the 24 remainders 18 were with the symptoms of thoracic discomfort after eating, 8 with dyspnea after activities, 14 with hiccup, vomiting and abdominal discomfort. Most of the patients had more than one symptom. All patients received operations via the chest cavity under general anesthesia, 24 cases were performed by double mattress suture with diaphragm discission, while 2 cases by fold suture without diaphragm discission. Results Symptoms relief was reported in 24 patients at the early stage after operation. Eighteen patients were followed up for one year, and 15 of them received chest radiograph, among whom the normal diaphragm localization were in 13 cases and relatively higher diaphragm localization in 2 cases, while the other 3 patients received no re-examination of chest radiograph. Among the 18 cases receiving one year of follow-up, 10 cases got complete disappearance of symptoms, 6 cases got symptoms relieved or partially disappeared, and 2 patients got symptom relapsed. Conclusion Surgical outcome, especially the double mattress suture is satisfactory for adult diaphragmatic eventration.
10.THE DIAGNOSIS AND TREATMENT OF PULMONARY SCLEROSING HEMANGIOMA
Xiaodong TIAN ; Naikang ZHOU ; Mengl ZHENG
Medical Journal of Chinese People's Liberation Army 1983;0(05):-
Forty patients with pulmonary sclerosing hemangioma treated from 1971 to 1999 in General itospital of PLA were analyzed retrospectively for clinical and pathological features,and image characteristics. The results showed that 60%(24 of 40) of patients were middle aged or elderly women,and 40% (16 of 40) of patients had symptoms.On chest radiography,the tumor presented as a round or nearly round nodule or mass with sharp and smooth margin in 37 cases(92 5%).All patients received operation without complication or mortality.Immunohistochemical findings indicated that the tumor cells were positive for neuroendocrine markers,and neurosecretory granules were found in tumor cells by electron microscopy.There was no recurrence or metastasis at the follow up. It suggested that pulmonary sclerosing hemangioma is a benign neuroendocrine tumor that has a good prognosis if it is treated by operation.